Clinical Trial Update: A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney Transplantation [Phase 1]

View source ↗

Summary

Phase 1 study update reporting pharmacokinetic, pharmacodynamic, safety and tolerability assessments of ASKP1240 in de novo kidney transplant recipients; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• ASKP1240

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 1 | Status: COMPLETED